JHEP Reports (Jan 2024)

Liver transplant selection criteria and outcomes in critically ill patients with ACLF

  • Sophie-Caroline- Sacleux,
  • Philippe Ichaï,
  • Audrey Coilly,
  • Marc Boudon,
  • Elise Lemaitre,
  • Rodolphe Sobesky,
  • Eleonora De Martin,
  • Valérie Cailliez,
  • Ilias Kounis,
  • Edoardo Poli,
  • Marie-Amélie Ordan,
  • Alina Pascale,
  • Jean-Charles Duclos-Vallée,
  • Cyrille Feray,
  • Daniel Azoulay,
  • Eric Vibert,
  • Daniel Cherqui,
  • René Adam,
  • Didier Samuel,
  • Faouzi Saliba

Journal volume & issue
Vol. 6, no. 1
p. 100929

Abstract

Read online

Background & Aims: Retrospective studies have reported good results with liver transplantation (LTx) for acute-on-chronic liver failure (ACLF) in selected patients. The aim of this study was to evaluate the selection process for LTx in patients with ACLF admitted to the intensive care unit (ICU) and to assess outcomes. Methods: This prospective, non-interventional, single high-volume center study collected data on patients with ACLF admitted to the ICU between 2017-2020. Results: Among 200 patients (mean age: 55.0 ± 11.2 years and 74% male), 96 patients (48%) were considered potential candidates for LTx. Unfavourable addictology criteria (n = 76) was the main reason for LTx ineligibility. Overall, 69 patients were listed for LTx (34.5%) and 50 were transplanted (25% of the whole population). The 1-year survival in the LTx group was significantly higher than in the non-transplanted group (94% vs. 15%, p 85.4% in those experiencing an increase of 2 organ failures since admission or >91% if experiencing an increase >2 organ failures, at which point futility could be considered. Conclusion: This prospective analysis of outcomes of patients with ACLF admitted to the ICU highlights the drastic nature of selection in this setting. Unfavourable addictology criteria, mechanical ventilation and increasing number of organ failures since admission were predictive of absence of LTx, futility and death. Impact and implications: Liver transplantation (LT) is the best therapeutic option in selected cirrhotic patients admitted to the ICU with acute on chronic liver failure. However, the selection criteria are poorly described and based on retrospective studies. This is the first prospective study that aimed to describe the selection process for LT in a transplant center. Patients with ACLF should be admitted to the ICU and evaluated within a short period of time for LT. In the context of organ shortage, eligibility for LT and either absence of LT, futility of care or death are better clarified in our study. These are mainly determined by prolonged respiratory failure and worsening of organ failures since ICU admission. Considering worldwide variations in the etiology and definition of ACLF, transplant availability and a narrow therapeutic window for transplant further prospective studies are awaited.

Keywords